PGK1 and adenocarcinoma: The data suggested that the overexpression of PGK1 was strongly associated with a poor overall survival and a progression-free survival in lung cancer, especially in the adenocarcinoma subtype, which has been thought to be the most common type of lung cancer clinically (Fig. 3C–F).